Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
| Metric | DVA | GILD |
|---|
| Close | 193.86 | 147.68 |
| Market Cap | $12.4B | $183B |
| 1M | +9.71% | +6.31% |
| P/E (TTM) | 14.4 | — |
| Forward P/E | 13.1 | 25.3 |
| P/E 5-Yr Percentile | 30 | — |
| P/S | 0.9 | 6.0 |
| P/B | — | 15.3 |
| Dividend Yield | — | 3.98% |
| Latest Quarter Revenue | $3.6B | $7.8B |
| Revenue YoY | +5.2% | +10.2% |
| Gross Margin | — | 79.8% |
| Latest Quarter EPS | 4.02 | -8.45 |
| Avg Post-Earnings Move | ±12.9% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 7.22% | 3.01% |
| 90-Day Net Insider Buying | — | −$15.4M |
DVA · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
